RENAL ANAEMIA

Clinical trials for RENAL ANAEMIA explained in plain language.

Never miss a new study

Get alerted when new RENAL ANAEMIA trials appear

Sign up with your email to follow new studies for RENAL ANAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to boost red blood cells in dialysis patients

Disease control Recruiting now

This study tests a new drug called pegmolesatide, alone or combined with roxadustat, to treat anemia in 240 adults on dialysis for chronic kidney disease. Participants currently on another anemia drug (rHuEPO) will switch to one of three treatment plans for 24 weeks. The goal is …

Matched conditions: RENAL ANAEMIA

Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control

Last updated Jun 26, 2026 15:52 UTC

RENAL ANAEMIA

Get alerted when new RENAL ANAEMIA trials appear

New combo therapy aims to boost red blood cells in dialysis patients